ArticleFrontiers in immunology2022

CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma.

Yanli Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.